UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053353
Receipt number R000060897
Scientific Title A Survey of the Factors Affecting the Mood and Emotional State in Physical Therapy
Date of disclosure of the study information 2024/01/15
Last modified on 2024/01/15 11:44:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Survey of the Factors Affecting the Mood and Emotional State in Physical Therapy

Acronym

A Survey of the Factors Affecting the Mood and Emotional State in Physical Therapy

Scientific Title

A Survey of the Factors Affecting the Mood and Emotional State in Physical Therapy

Scientific Title:Acronym

A Survey of the Factors Affecting the Mood and Emotional State in Physical Therapy

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the factors related to emotional state in physical therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Questionnaire on the Comfort and Mood State after Physical Therapy Treatment.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

5

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

NO treatment> Physical therapy P > Physical therapy Q > Physical therapy R > Physical therapy S > Physical therapy T

Interventions/Control_2

NO treatment > Physical therapy Q > Physical therapy R > Physical therapy S > Physical therapy T> Physical therapy P

Interventions/Control_3

NO treatment > Physical therapy R > Physical therapy S > Physical therapy T> Physical therapy P> Physical therapy Q

Interventions/Control_4

NO treatment> Physical therapy S > Physical therapy T> Physical therapy P> Physical therapy Q> Physical therapy R

Interventions/Control_5

NO treatment> Physical therapy T> Physical therapy P> Physical therapy Q> Physical therapy R> Physical therapy S

Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Healthy Participants aged 20-59
2. Person who voluntarily give their consent to participate in the study after receiving written explanations.

Key exclusion criteria

1. Person who had a drug allergic reaction.
2. Person who has one of the five major diseases (cancer, stroke, acute myocardial infarction, diabetes, psychiatric disease) and are undergoing treatment at a medical institution or are planning surgery.
3. Person who is judged by the principal investigator to be inappropriate to participate in the research due to other reasons such as noncompliance with compliance obligations.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Ryotaro
Middle name
Last name Yanagisawa

Organization

Kao Corporation

Division name

Human health care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7282

Email

yanagisawa.ryoutarou@kao.com


Public contact

Name of contact person

1st name Aya
Middle name
Last name Chiba

Organization

Kao Corporation

Division name

Human health care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7282

Homepage URL


Email

chiba.aya@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 12 Month 13 Day

Date of IRB

2023 Year 12 Month 13 Day

Anticipated trial start date

2024 Year 01 Month 15 Day

Last follow-up date

2024 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 15 Day

Last modified on

2024 Year 01 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060897